UPDATED-NIH Furloughs to Widen—From Slowdown to Shutdown, U.S. Science Takes a Hit

Drosophila melanogasterThe USDA is closed and no U.S. orders for international fruit
flies can be processed until the government is back in business.
Photo Credit: André KarwathU
UPDATED—The "Activation Energy" blog has learned that NIH will soon be forced to furlough even more Bethesda employees. SEE BELOW

When I saw the federal government shutdown heading inexorably toward us three weeks ago, I discussed with Kevin Wilson, the ASCB Public Policy Director, the idea of organizing a press conference to protest the further damage that a government shutdown would inflict on science. All along, I was hoping we would not have to do this and that reason will somehow prevail in Congress. Then I thought, "Reason? Congress?" We made a reservation for a meeting room at the prestigious National Press Club in Washington, DC, where news happens.

I confess that we thought that choosing October 8, the day after the Nobel Prize for medicine was to be announced, it might be a good strategy for amplifying our message—Here would be great scientists given a great award for a great basic science discovery that advanced knowledge and human health. Little did we know when we picked the date that our very own ASCB past President Randy Schekman and longtime ASCB member Jim Rothman would, along with Tom Südhof, win the highest honor in world science, the Nobel Prize for Physiology or Medicine. This wonderful news provided the perfect backdrop for our bleak message—the effect of the federal shutdown on basic research won't be temporary.

The shutdown comes on the heels of many bad years for science budgets. As we have stumbled from slowdowns to sequestration and now to a federal shutdown, our country's leadership in world science has clearly weakened. While America keeps slamming the brakes on scientific research, we are, in effect, accelerating the damage done to our longtime leadership in global bioscience, in health outcomes, and in the economic power that we have always derived from basic research. Americans will pay dearly for these slowdowns, sequestrations, and shutdowns. It is no secret that this prolonged gridlock is further slowing down science and not just inside the Beltway. The impact is spreading outward like a shock wave through laboratories across America. The slowdown and the shutdown will have real consequences in finding cures and on maintaining economic competitiveness.

The shutdown is already slowing down science in small but critical ways. Ruth Lehman, the Director of the Skirball Institute at New York University, is a fly geneticist. She depends on fly strains held at international stock centers that can be shared by researchers worldwide. She needed an RNAi fly line from the Vienna Drosophila RNAi Center in Austria. She ordered it through the USDA, only to receive an automatic reply that because the USDA is closed, no orders can be processed to the U.S. until the government is back in business. A fruit fly may seem very small to our politicians but in our science it is a mighty genetic engine for discovery. For the want of a fruit fly, the government shutdown has isolated one highly productive American scientist. For the want of a fruit fly and consistent, long term funding of basic biomedical research, the U.S. healthcare and U.S. competiveness will continue accelerating toward "also ran" status.

We may think of research as a gleaming, high-tech enterprise but real science is a very fragile ecosystem with many players swimming in it. The federal government plays an essential role: Without a functional government supporting the science infrastructure, discoveries and health outcomes will take a body blow.

There are 1,300 program officers at NIH. These are government scientists who help scientists in universities and research centers get their science funded and off the ground. They are all sitting at home today, furloughed. Why are they important? Let me answer with a real-life example. It concerns Tom Südhof—who won the Nobel Prize this week and the Lasker Prize last month. When Tom learned that he'd won the Lasker, not only did he publicly thank his program director at NIH, Chiiko Stanfield, but Südhof invited her to be his personal guest at the flashy Lasker award ceremony in New York. A seat at the Laskers is a hot ticket but Südhof made it a priority to recognize the essential role that his program officer played in the making of the science that the Lasker honors.

Chiiko is now furloughed. Her other scientists who might win a Lasker Award or a Nobel Prize are unable to reach her by email or phone. In the 21st century, Chiiko and NIH are offline.

There are 300 review officers at NIH. These scientists run the study sections that review grants. They are all at home today. No new science is being reviewed. We are frozen in place this morning. We face massive challenges in health care—Alzheimer's, cancer, new contagious diseases, old genetic killer— but NIH is closed today.

Fifteen percent of all NIH grants are cooperative agreements, where NIH scientists partner with extramural scientists. The government shutdown is slowing down science because the NIH partners are not there.

UPDATE-- Sadly enough, the feeling is that things will get worse before getting better. The "Activation Energy" blog has learned that NIH will soon be forced to furlough even more employees. Things are already eerily quiet on the NIH Bethesda campus and now science will take an even bigger blow.

In addition, my concern is that even when the NIH reopens for business, it will take time before science operations return to normal. I am particularly concerned about study sections. The backlog of canceled review sessions will impose massive rescheduling challenges. The best service to the community that ASCB members could provide on this front is that when asked to serve on a study section to make an extra effort to say yes. There will be an enormous need to move the review process and grant funding forward as quickly as possible. ASCB members need to pitch in as never before.

Science is an ecosystem, where every creature matters. If we snuff out one of the partners, we compromise the whole system. I came to the U.S. as a graduate student, seeking a place that had a vibrant and well-coordinated ecosystem of science. Today I fear that we have forgotten how important this is. Today I am wondering what U.S. science will look like in a week or a month or five years. Young scientists are not cave people. They can see labs going dark all across America. One day we may flip the lights back on and find the labs empty. A whole generation of scientific talent may have gone elsewhere.

Stefano Bertuzzi

Dr. Stefano Bertuzzi is the Executive Director of the American Society for Cell Biology. In this position he is responsible, with the ASCB Board, for strategic planning and all operations at the Society to serve the needs of its ~9,000 members and to promote the field of cellular biology and basic science.

Email This email address is being protected from spambots. You need JavaScript enabled to view it.

Most Recent Articles *

To read the full article, click on the READ MORE button below.

  • 1
  • 2
  • 3
  • 4
Prev Next
ASCB Kaluza Prize Reflects ASCB’s Concern that Young Scientists Are Now a Vulnerable Population

ASCB Kaluza Prize Reflects ASCB’s Concern that Young Scientists Are Now a Vulnerable Population

The ASCB Kaluza Prize recognizes significant research achievement by early career scientists who still pursue excellence amidst economic uncertainties and political shortsightedness. ASCB Photo.In the...

11-20-2013

Read more
Round Trip from Stockholm to ASCB

Round Trip from Stockholm to ASCB

With Stockholm still in the future, Randy Schekman (third from left) with fellow 2013 Nobel winner, Jim Rothman (far right), shared the ASCB's highest scientific honor, the E. B. Wilson Medal, with St...

11-06-2013

Read more
Colliding Worlds—A Rare Visit to the CERN Collider Gives a Biologist New Hope

Colliding Worlds—A Rare Visit to the CERN Collider Gives a Biologist New Hope

Nearly 170 meters beneath CERN, ASCB Executive Director Stefano Bertuzzi gets a rare look at the Large Hadron Collider. Here he stands in front of the detector. Photo Credit: ASCBLast week, I was invi...

10-23-2013

Read more
Watching Train Wrecks

Watching Train Wrecks

It’s full steam ahead for disaster or will the brakes stop the runaway fiscal crisis train in time? Photo by John FleischmanAlong with the future of U.S. research science, the train wreck metaphor has...

10-16-2013

Read more
Shutting Down Basic Science—Some Thoughts at Midnight (no, this is not a fairy tale)

Shutting Down Basic Science—Some Thoughts at Midnight (no, this is not a fairy tale)

Last night at midnight, the government ran out of money and shut down its main operations. Sadly, it left me wondering if perhaps our democracy ran out of steam as well. I've tried to explain what is ...

10-01-2013

Read more
New Partners and New Ventures for ASCB in Science Education Reform

New Partners and New Ventures for ASCB in Science Education Reform

In a 2012 Science editorial, Bruce Alberts, a former ASCB president who was then the journal's editor, urged professional societies to team up in leading innovation in science education. ASC...

09-25-2013

Read more
The Scholarly Paper That No One Will Want to Read Is Being Written in Congress

The Scholarly Paper That No One Will Want to Read Is Being Written in Congress

Spelling It Out: Spending on basic research has increased our longevity and the quality of that longer life. Photo Credit: John FleischmanThis week, a paper in the American Journal of Public Health, a...

09-18-2013

Read more
A Scientist-Senator with a Seat — and a Vote — for Life

A Scientist-Senator with a Seat — and a Vote — for Life

I recently spent some time on a family vacation in Italy. We have a tradition in our family; at the dinner table, each of us has to say the best and the worst thing that happened to him or her during ...

09-10-2013

Read more
Showing the Faces of Science

Showing the Faces of Science

In 2011, the Nobel Foundation awarded its prize of prizes to cell biologist, immunologist, and longtime ASCB member Ralph Steinman. When the foundation tried calling to deliver the good news, no one p...

09-05-2013

Read more
Lessons from a Society of Societies

Lessons from a Society of Societies

This week, ASCB went to ASAE, or rather five ASCB staffers and yours truly attended a meeting of the ASAE in Atlanta. ASCB, I trust you know, stands for the American Society for Cell Biology. The ASAE...

08-07-2013

Read more
Why Congress Should Be Worried About the Endoplasmic Reticulum

Why Congress Should Be Worried About the Endoplasmic Reticulum

Morphogenesis in biology always fascinated me. As a developmental neurobiologist at the bench, I studied how homeobox genes patterned the neural epithelium, the retina in particular, to understand the...

07-30-2013

Read more
The Perils of Reviewing Peer Review

The Perils of Reviewing Peer Review

As a recovering federal employee, I recognize that one of the biggest challenges the government faces in funding science is that of being truly Darwinian in a rapidly evolving scientific environment. ...

07-24-2013

Read more